(Q25256891)

6 July 2017

title

Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer (English)

1 reference

6 July 2017

0 references

1 reference

Rong Yu Zang

1

1 reference

6 July 2017

Zi Ting Li

2

1 reference

6 July 2017

Jie Tang

3

1 reference

6 July 2017

Xiao Huang

4

1 reference

6 July 2017

Shu Mo Cai

5

1 reference

6 July 2017

language of work or name

English

0 references

publication date

19 January 2006

1 reference

World Journal of Surgical Oncology

6 July 2017

published in

1 reference

6 July 2017

volume

4

1 reference

6 July 2017

issue

1

0 references

page(s)

4

1 reference

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373630

Intraperitoneal therapy for ovarian cancer: a sacrifice bunt

31 May 2018

1 reference

12 December 2020

[Impacts of chemotherapy on long-term survival of patients with advanced epithelial ovarian cancer]

1 reference

12 December 2020

Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy

1 reference

12 December 2020

Hyperthermic peritoneal perfusion system in canines

1 reference

12 December 2020

Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7819-4-4

1 reference

Dimensions Publication ID

6 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1477-7819-4-4

9 September 2019

1 reference

6 July 2017

1 reference